alarm-ringing ambulance angle2 archive arrow-down arrow-left arrow-right arrow-up at-sign baby baby2 bag binoculars book-open book2 bookmark2 bubble calendar-check calendar-empty camera2 cart chart-growth check chevron-down chevron-left chevron-right chevron-up circle-minus circle city clapboard-play clipboard-empty clipboard-text clock clock2 cloud-download cloud-windy cloud clubs cog cross crown cube youtube diamond4 diamonds drop-crossed drop2 earth ellipsis envelope-open envelope exclamation eye-dropper eye facebook file-empty fire flag2 flare foursquare gift glasses google graph hammer-wrench heart-pulse heart home instagram joystick lamp layers lifebuoy link linkedin list lock magic-wand map-marker map medal-empty menu microscope minus moon mustache-glasses paper-plane paperclip papers pen pencil pie-chart pinterest plus-circle plus power pushpin question rain reading receipt recycle reminder sad shield-check smartphone smile soccer spades speed-medium spotlights star-empty star-half star store sun-glasses sun tag telephone thumbs-down thumbs-up tree tumblr twitter user users wheelchair write yelp youtube

Higher, Lower HbA1c Levels Associated With Worse Outcomes In CKD With Diabetes.

Higher, Lower HbA1c Levels Associated With Worse Outcomes In CKD With Diabetes.

MedPage Today Share to FacebookShare to Twitter (11/29, Neale) reports, “Among patients with diabetes and stage 3 or 4 chronic kidney disease, glycated hemoglobin levels that are too low are associated with worse clinical outcomes, just as are levels that are too high,” according to a study Share to FacebookShare to Twitter in the Nov. 28 issue of Archives of Internal Medicine. “Higher glycated hemoglobin (HbA1c) levels at baseline were associated with greater risks of death, progression of kidney disease, new end-stage renal disease, cardiovascular events, and all-cause hospitalization (P<0.001 for all trends)." However, "for mortality in particular, an HbA1c level that was too low — less than 6.5% — also was associated with an elevated risk." An accompanying editorial Share to FacebookShare to Twitter “called for randomized controlled trials to better inform the discussion about the best approaches for managing risk factors in patients with advanced kidney disease.”